Immunosuppression for clinical pancreas transplantation
- 1 December 1991
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 5 (6pt2) , 549-553
- https://doi.org/10.1111/j.1399-0012.1991.tb00233.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- SERUM IMMUNOREACTIVE ANODAL TRYPSINOGEN AND URINARY AMYLASE AS BIOCHEMICAL MARKERS FOR REJECTION OF CLINICAL WHOLE-ORGAN PANCREAS ALLOGRAFTS HAVING EXOCRINE DRAINAGE INTO THE URINARY BLADDERTransplantation, 1990
- A 10-Year Experience with 290 Pancreas Transplants at a Single InstitutionAnnals of Surgery, 1989
- Pancreas transplantationCurrent Opinion in Immunology, 1989
- Rejection of Kidney and Pancreas After Pancreas-Kidney TransplantationDiabetes, 1989
- Pancreas-Specific Protein New Serum Marker for Graft Rejection in Pancreas-Transplant RecipientsDiabetes, 1989
- Experience with Simultaneous Pancreas-kidney TransplantationAnnals of Surgery, 1988
- Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretionThe American Journal of Surgery, 1987
- IMPROVED RESULTS IN PANCREATIC TRANSPLANTATION BY AVOIDANCE OF NONIMMUNOLOGICAL GRAFT FAILURESTransplantation, 1987
- EXPERIMENTAL AND CLINICAL EXPERIENCE WITH URINE AMYLASE MONITORING FOR EARLY DIAGNOSIS OF REJECTION IN PANCREAS TRANSPLANTATIONTransplantation, 1987
- SUCCESSFUL OUTCOME OF SEGMENTAL HUMAN PANCREATIC TRANSPLANTATION WITH ENTERIC EXOCRINE DIVERSION AFTER MODIFICATIONS IN TECHNIQUEThe Lancet, 1982